Showing 1 - 13 results of 13 for search 'Jing H. Wang', query time: 0.06s
Refine Results
-
1
-
2
-
3
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders by Jessy John, Samantha M. Y. Chen, Rachel A. Woolaver, Huaibin Ge, Monika Vashisht, Ziyu Huang, Zhangguo Chen, Jing H. Wang, Jing H. Wang
Published 2023-03-01
Article -
4
-
5
Differential tumor immune microenvironment coupled with tumor progression or tumor eradication in HPV-antigen expressing squamous cell carcinoma (SCC) models by Arpitha H. Shivarudrappa, Jessy John, Monika Vashisht, Huaibin Ge, Silvia Liu, Jingxin Chen, Karen Siddoway, Rui Dong, Rui Dong, Zhangguo Chen, Jing H. Wang, Jing H. Wang
Published 2024-07-01
Article -
6
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumor... by Jessy John, Rachel A. Woolaver, Vince Popolizio, Samantha M. Y. Chen, Huaibin Ge, Alexandra L. Krinsky, Monika Vashisht, Yonatan Kramer, Zhangguo Chen, Jing H. Wang, Jing H. Wang
Published 2022-10-01
Article -
7
-
8
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs by Monika Vashisht, Huaibin Ge, Jessy John, Harlie A. McKelvey, Jingxin Chen, Zhangguo Chen, Jing H. Wang
Published 2023-09-01
Article -
9
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma by Xiaoguang Wang, Brittany C. Waschke, Rachel A Woolaver, Samantha M. Y. Chen, Zhangguo Chen, Jing H. Wang
Published 2020-03-01
Article -
10
-
11
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma by Alexander A. Strait, Rachel A. Woolaver, Spencer C. Hall, Christian D. Young, Sana D. Karam, Antonio Jimeno, Yan Lan, David Raben, Jing H. Wang, Xiao-Jing Wang
Published 2021-08-01
Article -
12
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers by Samantha M. Y. Chen, Vince Popolizio, Rachel A. Woolaver, Huaibin Ge, Alexandra L. Krinsky, Jessy John, Etienne Danis, Yao Ke, Yonatan Kramer, Li Bian, Andrew G. Nicklawsky, Dexiang Gao, Silvia Liu, Zhangguo Chen, Xiao-jing Wang, Jing H. Wang
Published 2022-04-01
Article -
13
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes by Juan A. Marín-Jiménez, Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro, Hui Yu, Hui Yu, Chris J. Rivard, Chris J. Rivard, Xiaoguang Wang, Jessica C. Barkow, Degui Geng, Adwitiya Kar, Ashley Yingst, Dejene M. Tufa, James T. Dolan, Patrick J. Blatchford, Brian M. Freed, Brian M. Freed, Raul M. Torres, Raul M. Torres, Eduardo Davila, Eduardo Davila, Jill E. Slansky, Jill E. Slansky, Roberta Pelanda, Roberta Pelanda, S. Gail Eckhardt, Wells A. Messersmith, Wells A. Messersmith, Jennifer R. Diamond, Jennifer R. Diamond, Christopher H. Lieu, Michael R. Verneris, Jing H. Wang, Jing H. Wang, Katja Kiseljak-Vassiliades, Katja Kiseljak-Vassiliades, Todd M. Pitts, Todd M. Pitts, Julie Lang
Published 2021-03-01
Article